Chester County News and Community Website
WASHINGTON, D.C. — President Donald Trump and British Prime Minister Keir Starmer have reached an agreement in principle on pharmaceutical pricing that U.S. officials say could reshape the global drug …
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance Read More
WILMINGTON, DE — A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: predicting how the human heart will respond …
Virtual Hearts, Real Stakes: $30M ARPA-H Bet Targets Drug Cardiac Risk Read More
WASHINGTON, D.C. — The United States and the United Kingdom reached a sweeping agreement in principle last week to rebalance pharmaceutical pricing between the two nations, marking a rare international …
U.S. Strikes Breakthrough Drug-Pricing Deal With U.K., Promising Major Shift in Global Pharma Costs Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced a sweeping set of reforms and enforcement actions last week aimed at lowering prescription drug costs and protecting children from …
FDA Cracks Down on Unapproved Fluoride Drugs, Fast-Tracks Cheaper Biologic Alternatives Read More
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More
WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) released its final guidance for the third cycle of the Medicare Drug Price Negotiation Program on Tuesday, introducing major …
CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services last week rolled out a series of high-profile actions aimed at reshaping child health policy, tightening oversight of pharmaceutical …
HHS Unveils Sweeping Child Health Strategy, Moves to Tighten Drug Ads and Block Illegal E-Cigarettes Read More
WASHINGTON, D.C. — The Food and Drug Administration launched a series of major enforcement and transparency initiatives last week, ranging from cracking down on deceptive pharmaceutical advertising to seizing a …
FDA Cracks Down on Drug Ads, Seizes $86M in Illegal Vapes, Pushes Non-Opioid Pain Relief Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration has unveiled FDA PreCheck, a new initiative designed to strengthen the domestic pharmaceutical supply chain by making the process of building …
FDA Launches PreCheck Program to Boost Domestic Drug Manufacturing Read More
WILMINGTON, DE — AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals …
AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site Read More